Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)]
- Citation:
- ESMO Open vol 9 (11)
- Year:
- 2024
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- collection
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 15
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, UG1CA232760; UG1CA233180, UG1CA233196, UG1CA233329, UG1CA233337, U10CA180820 (ECOG-ACRIN); U10CA180863 (Canadian Clinical Trials Group) and grant 704970 from the Canadian Cancer Society; U10CA180888 (SWOG)
- Corr. Author:
- Authors:
- E. de Azambuja M. Piccart-Gebhart S. Fielding J. Townend D.W. Hillman M. Colleoni R. Roylance C.M. Kelly J. Lombard S. El-Abed A. Choudhury L. Korde M. Vicente S. Chumsri R. Rodeheffer S.L. Ellard A.C. Wolff J. Holtschmidt I. Lang M. Untch F. Boyle B. Xu G. Werutsky J. Tujakowski C.-S. Huang N.B. Baruch J. Bliss A. Ferro J. Gralow S.-B. Kim J.R. Kroep I. Krop S. Kuemmel R. McConnell L. Moscetti A.S. Knop F. van Duijnhoven H. Gomez D. Cameron S. Di Cosimo R.D. Gelber A. Moreno-Aspitia
- Networks:
- AL068, LAPS-CT018, LAPS-MA036, LAPS-MD017, LAPS-MN026, LAPS-NY016, SC019
- Study
- NCCTG-N063D
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: